News & Opinion

Covering the life sciences inside and out

An investigation finds 20 papers by Santosh Katiyar, who studied alternative treatments for cancer, include image manipulation.

Researchers have been using ultrasound to control brain activity, but studies in mice and guinea pigs show it also stimulates the auditory system, presenting a confounder for direct neural stimulation.

Determining which products of advanced biotechnology are deserving of legal protections is essential to our own social architecture.

The finding confirms that a cluster of cells that directs the fate of other cells in the developing embryo is evolutionarily conserved across the animal kingdom.

The Nutshell

Daily News Roundup

The micro-bio-electronic device combines bacteria that can detect certain molecules along with wifi-connected electrical outputs.

A mass extinction event from an asteroid hitting Earth wiped out forests and, concurrently, tree-dwelling birds.  

One patient with diabetes was able to reduce his medication use while receiving targeted electrical pulses.

Ecological challenges such as finding food and creating fire may have led the organ to become abnormally large, a new computer model suggests.

Current Issue

May 2018

Issue Cover: Rare Diseases

When the O’Neills learned that their daughter had Sanfilippo syndrome, a devastating rare disease, they created a GoFundMe campaign that raised $2 million in less than a year.

Clinical analyses of patients’ gene sequences are helping to provide answers where none were available before.

Crowdfunding can power investigations into diseases that would otherwise receive little attention.

Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.

Multimedia

Video, Slideshows, Infographics

Ali Guthy, the daughter of cosmetics entrepreneur Victoria Jackson, discusses NMO, the rare autoimmune disease she suffers from.

Watch the viral video that helped the family of a child with Sanfilippo syndrome raise more than $2 million.

The Marketplace

Sponsored Product Updates

Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that its research collaboration with FIT Biotech Oy (FITBIO:FN Finland) has successfully completed a proof-of-concept study with very encouraging data, showing sustained production of Affimer molecules by the muscle tissue of mice.

Today, Lonza announced the addition of hepatic stellate cells, Kupffer cells and liver-derived endothelial cells to its extensive hepatocytes portfolio. These hepatic non-parenchymal cells provide scientists with the building blocks to create more physiologically relevant in vitro models, including co-cultures and 3D cell cultures, for enhanced liver disease research.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the release of a range of anti-vedolizumab antibodies.

Bio-Rad Laboratories Inc. (NYSE: BIO and BIOb) today announced the launch of StarBright Blue 520 Fluorescent Secondary Antibodies, fluorescent dye–labeled secondary antibodies for use in multiplex western blotting.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSymphony™ S6 cell sorter, which will be on display at the 33rd Congress of the International Society for Advancement of Cytometry next week in Prague.

SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), today announced the introduction of 2view™, a unique detection method optimised for Western blotting, under its Expedeon brand name.  

Popular Now

  1. How to Separate the Science From the (Jerk) Scientist
  2. Could a Dose of Sunshine Make You Smarter?
  3. Sweden Cancels Agreement With Elsevier Over Open Access
  4. Prevalent Form of Childhood Leukemia May Be Preventable

Featured Comment

I remember watching GATTACA with some other grad students in the 90's, we liked it but laughed at the 'impossible' fast sequencing done to validate people's identities. Now we do seven impossible things before breakfast, so to speak.

Allison Mackay, commenting on The Scientist's story about a new, hand-held sequencer that can reportedly decode the entire human genome.

Pocket-Size Nanopore Device Sequences Entire Human Genome